Incidences of liver cancer rising in the USA

Black women found to have denser breast tissue than white women

New data shows that generic drivers are found in benign conditions

ecancermedicalscience editor's choice for April 2015

Positive results in phase II study of copanlisib treating NHL and CLL

Dual mTOR inhibition effective in reducing tumour load in CLL

Putting the patient at the centre of cancer-associated thrombosis treatment decisions

Pembrolizumab showed clinical benefit in malignant pleural mesothelioma

Chk1 inhibition combined with standard dose gemcitabine may be safe and effective

Updated results on phase III CLL trial shows 90% response rate using ibrutinib

BRAF 'behind the scenes' in melanoma: A scientific story of discovery

Connecting science, practice and patient outcomes: Use of BRAF inhibitors for treating metastatic melanoma in clinical practice